nodes	percent_of_prediction	percent_of_DWPC	metapath
Degarelix—GNRHR—hindbrain—epilepsy syndrome	0.0236	0.334	CbGeAlD
Degarelix—GNRHR—brainstem—epilepsy syndrome	0.0135	0.192	CbGeAlD
Degarelix—GNRHR—head—epilepsy syndrome	0.00748	0.106	CbGeAlD
Degarelix—GNRHR—nervous system—epilepsy syndrome	0.00709	0.1	CbGeAlD
Degarelix—GNRHR—central nervous system—epilepsy syndrome	0.00683	0.0967	CbGeAlD
Degarelix—GNRHR—cerebellum—epilepsy syndrome	0.00668	0.0945	CbGeAlD
Degarelix—GNRHR—brain—epilepsy syndrome	0.00542	0.0767	CbGeAlD
Degarelix—GNRHR—G alpha (q) signalling events—AVP—epilepsy syndrome	0.000856	0.0033	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GAL—epilepsy syndrome	0.000831	0.0032	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—epilepsy syndrome	0.000827	0.00319	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL2—epilepsy syndrome	0.000827	0.00319	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—OXT—epilepsy syndrome	0.000827	0.00319	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CHRM3—epilepsy syndrome	0.000821	0.00316	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GRM5—epilepsy syndrome	0.000821	0.00316	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ACKR4—epilepsy syndrome	0.000811	0.00313	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SSTR5—epilepsy syndrome	0.000808	0.00311	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SSTR4—epilepsy syndrome	0.000808	0.00311	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CX3CR1—epilepsy syndrome	0.000787	0.00303	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR10—epilepsy syndrome	0.000775	0.00299	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—BDKRB1—epilepsy syndrome	0.000772	0.00298	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CX3CL1—epilepsy syndrome	0.000772	0.00298	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CHRM2—epilepsy syndrome	0.000772	0.00298	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	0.000765	0.00295	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—GABBR1—epilepsy syndrome	0.000751	0.00289	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	0.000748	0.00288	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	0.000748	0.00288	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SSTR5—epilepsy syndrome	0.000734	0.00283	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SSTR4—epilepsy syndrome	0.000734	0.00283	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	0.000732	0.00282	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HRH3—epilepsy syndrome	0.00072	0.00278	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—HTR2A—epilepsy syndrome	0.000712	0.00274	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—OPRM1—epilepsy syndrome	0.000709	0.00273	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR10—epilepsy syndrome	0.000704	0.00271	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	0.000703	0.00271	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	0.000703	0.00271	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	0.00069	0.00266	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM2—epilepsy syndrome	0.000677	0.00261	CbGpPWpGaD
Degarelix—GNRHR—G alpha (q) signalling events—AGT—epilepsy syndrome	0.000675	0.0026	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	0.000673	0.00259	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR3—epilepsy syndrome	0.00067	0.00258	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—NPY—epilepsy syndrome	0.000652	0.00251	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	0.000637	0.00245	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCL2—epilepsy syndrome	0.00063	0.00243	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL3—epilepsy syndrome	0.00063	0.00243	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CRH—epilepsy syndrome	0.00063	0.00243	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—OXT—epilepsy syndrome	0.00063	0.00243	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM2—epilepsy syndrome	0.000615	0.00237	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SSTR3—epilepsy syndrome	0.000612	0.00236	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	0.000604	0.00233	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	0.000587	0.00226	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY2R—epilepsy syndrome	0.000587	0.00226	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SSTR1—epilepsy syndrome	0.000587	0.00226	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR8—epilepsy syndrome	0.000587	0.00226	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR9—epilepsy syndrome	0.000587	0.00226	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM4—epilepsy syndrome	0.000576	0.00222	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM3—epilepsy syndrome	0.000576	0.00222	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—SST—epilepsy syndrome	0.000569	0.00219	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR2—epilepsy syndrome	0.000569	0.00219	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	0.000567	0.00218	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SSTR2—epilepsy syndrome	0.000565	0.00218	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—ADRA2A—epilepsy syndrome	0.000557	0.00215	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SSTR3—epilepsy syndrome	0.000556	0.00214	CbGpPWpGaD
Degarelix—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	0.000556	0.00214	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRICKLE1—epilepsy syndrome	0.000548	0.00211	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRDM4—epilepsy syndrome	0.000548	0.00211	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM8—epilepsy syndrome	0.000546	0.0021	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CXCL12—epilepsy syndrome	0.000535	0.00206	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—BDKRB2—epilepsy syndrome	0.000535	0.00206	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ARHGEF9—epilepsy syndrome	0.000533	0.00205	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY2R—epilepsy syndrome	0.000533	0.00205	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SSTR1—epilepsy syndrome	0.000533	0.00205	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR8—epilepsy syndrome	0.000533	0.00205	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR9—epilepsy syndrome	0.000533	0.00205	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CNR1—epilepsy syndrome	0.000525	0.00202	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM3—epilepsy syndrome	0.000523	0.00201	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM4—epilepsy syndrome	0.000523	0.00201	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—OPRD1—epilepsy syndrome	0.000521	0.00201	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SSTR2—epilepsy syndrome	0.000513	0.00198	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR7—epilepsy syndrome	0.000513	0.00198	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CHRM1—epilepsy syndrome	0.000499	0.00192	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR7—epilepsy syndrome	0.000499	0.00192	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PDYN—epilepsy syndrome	0.000499	0.00192	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM1—epilepsy syndrome	0.000499	0.00192	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM8—epilepsy syndrome	0.000496	0.00191	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	0.000482	0.00186	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ACKR4—epilepsy syndrome	0.000479	0.00185	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—OPRD1—epilepsy syndrome	0.000473	0.00182	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GNAO1—epilepsy syndrome	0.000473	0.00182	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	0.000471	0.00182	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GAL—epilepsy syndrome	0.000469	0.00181	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GRM5—epilepsy syndrome	0.000464	0.00179	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CHRM3—epilepsy syndrome	0.000464	0.00179	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CHRM1—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM1—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PDYN—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR7—epilepsy syndrome	0.000453	0.00175	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	0.000447	0.00172	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—BDKRB1—epilepsy syndrome	0.000436	0.00168	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CHRM2—epilepsy syndrome	0.000436	0.00168	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SSTR5—epilepsy syndrome	0.000434	0.00167	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SSTR4—epilepsy syndrome	0.000434	0.00167	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AVP—epilepsy syndrome	0.000431	0.00166	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GAL—epilepsy syndrome	0.000426	0.00164	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—GABBR1—epilepsy syndrome	0.000425	0.00164	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GRM5—epilepsy syndrome	0.000422	0.00162	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CHRM3—epilepsy syndrome	0.000422	0.00162	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR10—epilepsy syndrome	0.000416	0.0016	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HRH3—epilepsy syndrome	0.000407	0.00157	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CX3CR1—epilepsy syndrome	0.000404	0.00156	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—OPRM1—epilepsy syndrome	0.000401	0.00154	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CHRM2—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CX3CL1—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—BDKRB1—epilepsy syndrome	0.000396	0.00153	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—GABBR1—epilepsy syndrome	0.000386	0.00149	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR3—epilepsy syndrome	0.000378	0.00146	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	0.000377	0.00145	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HRH3—epilepsy syndrome	0.00037	0.00142	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—NPY—epilepsy syndrome	0.000369	0.00142	CbGpPWpGaD
Degarelix—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	0.000368	0.00142	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCR5—epilepsy syndrome	0.000367	0.00141	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—OPRM1—epilepsy syndrome	0.000364	0.0014	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM2—epilepsy syndrome	0.000363	0.0014	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—HTR2A—epilepsy syndrome	0.000359	0.00138	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CRH—epilepsy syndrome	0.000356	0.00137	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—OXT—epilepsy syndrome	0.000356	0.00137	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CXCL2—epilepsy syndrome	0.000356	0.00137	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR3—epilepsy syndrome	0.000344	0.00132	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—AGT—epilepsy syndrome	0.000341	0.00131	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—NPY—epilepsy syndrome	0.000335	0.00129	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SSTR3—epilepsy syndrome	0.000329	0.00127	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL3—epilepsy syndrome	0.000323	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CXCL2—epilepsy syndrome	0.000323	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—OXT—epilepsy syndrome	0.000323	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CRH—epilepsy syndrome	0.000323	0.00124	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CCR2—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—SST—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ST3GAL3—epilepsy syndrome	0.000322	0.00124	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ARHGEF9—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR9—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NPY2R—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SSTR1—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR8—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—ADRA2A—epilepsy syndrome	0.000315	0.00121	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM3—epilepsy syndrome	0.000309	0.00119	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM4—epilepsy syndrome	0.000309	0.00119	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—DUSP4—epilepsy syndrome	0.000303	0.00117	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SSTR2—epilepsy syndrome	0.000303	0.00117	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CXCL12—epilepsy syndrome	0.000302	0.00117	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—BDKRB2—epilepsy syndrome	0.000302	0.00117	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—CNR1—epilepsy syndrome	0.000297	0.00114	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—PLCB1—epilepsy syndrome	0.000296	0.00114	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM8—epilepsy syndrome	0.000293	0.00113	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PGF—epilepsy syndrome	0.000293	0.00113	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—SST—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCR2—epilepsy syndrome	0.000292	0.00113	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR7—epilepsy syndrome	0.00029	0.00112	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—POMC—epilepsy syndrome	0.000287	0.0011	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—ADRA2A—epilepsy syndrome	0.000286	0.0011	CbGpPWpGaD
Degarelix—GNRHR—GPCR ligand binding—CCL2—epilepsy syndrome	0.000281	0.00108	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—OPRD1—epilepsy syndrome	0.000279	0.00108	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GNAO1—epilepsy syndrome	0.000279	0.00108	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT3—epilepsy syndrome	0.000276	0.00106	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—BDKRB2—epilepsy syndrome	0.000275	0.00106	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CXCL12—epilepsy syndrome	0.000275	0.00106	CbGpPWpGaD
Degarelix—Asthenia—Zonisamide—epilepsy syndrome	0.000273	0.000408	CcSEcCtD
Degarelix—Mental disorder—Gabapentin—epilepsy syndrome	0.000273	0.000408	CcSEcCtD
Degarelix—Dry mouth—Valproic Acid—epilepsy syndrome	0.000273	0.000407	CcSEcCtD
Degarelix—Headache—Levetiracetam—epilepsy syndrome	0.000272	0.000406	CcSEcCtD
Degarelix—Malnutrition—Gabapentin—epilepsy syndrome	0.000271	0.000405	CcSEcCtD
Degarelix—Erythema—Gabapentin—epilepsy syndrome	0.000271	0.000405	CcSEcCtD
Degarelix—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00027	0.000404	CcSEcCtD
Degarelix—Dizziness—Vigabatrin—epilepsy syndrome	0.00027	0.000403	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CNR1—epilepsy syndrome	0.00027	0.00104	CbGpPWpGaD
Degarelix—Pruritus—Zonisamide—epilepsy syndrome	0.000269	0.000402	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—PLCB1—epilepsy syndrome	0.000269	0.00104	CbGpPWpGaD
Degarelix—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000269	0.000401	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CHRM1—epilepsy syndrome	0.000268	0.00103	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR7—epilepsy syndrome	0.000268	0.00103	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PDYN—epilepsy syndrome	0.000268	0.00103	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM1—epilepsy syndrome	0.000268	0.00103	CbGpPWpGaD
Degarelix—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000267	0.000399	CcSEcCtD
Degarelix—Urticaria—Lamotrigine—epilepsy syndrome	0.000267	0.000399	CcSEcCtD
Degarelix—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000267	0.000399	CcSEcCtD
Degarelix—Malaise—Pregabalin—epilepsy syndrome	0.000267	0.000399	CcSEcCtD
Degarelix—Nausea—Propofol—epilepsy syndrome	0.000267	0.000398	CcSEcCtD
Degarelix—Vomiting—Fosphenytoin—epilepsy syndrome	0.000266	0.000398	CcSEcCtD
Degarelix—Diarrhoea—Felbamate—epilepsy syndrome	0.000266	0.000397	CcSEcCtD
Degarelix—Abdominal pain—Lamotrigine—epilepsy syndrome	0.000266	0.000397	CcSEcCtD
Degarelix—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000266	0.000397	CcSEcCtD
Degarelix—Dizziness—Diazepam—epilepsy syndrome	0.000266	0.000397	CcSEcCtD
Degarelix—Rash—Fosphenytoin—epilepsy syndrome	0.000264	0.000394	CcSEcCtD
Degarelix—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000264	0.000394	CcSEcCtD
Degarelix—Asthenia—Clonazepam—epilepsy syndrome	0.000263	0.000393	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HTR7—epilepsy syndrome	0.000263	0.00101	CbGpPWpGaD
Degarelix—Back pain—Gabapentin—epilepsy syndrome	0.000263	0.000392	CcSEcCtD
Degarelix—Headache—Fosphenytoin—epilepsy syndrome	0.000262	0.000392	CcSEcCtD
Degarelix—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000262	0.000391	CcSEcCtD
Degarelix—Palpitations—Pregabalin—epilepsy syndrome	0.000262	0.000391	CcSEcCtD
Degarelix—Asthenia—Phenytoin—epilepsy syndrome	0.000262	0.000391	CcSEcCtD
Degarelix—Nausea—Midazolam—epilepsy syndrome	0.000261	0.00039	CcSEcCtD
Degarelix—Hypoaesthesia—Topiramate—epilepsy syndrome	0.000261	0.00039	CcSEcCtD
Degarelix—Muscle spasms—Gabapentin—epilepsy syndrome	0.000261	0.00039	CcSEcCtD
Degarelix—Diarrhoea—Zonisamide—epilepsy syndrome	0.000261	0.000389	CcSEcCtD
Degarelix—Asthenia—Oxcarbazepine—epilepsy syndrome	0.00026	0.000388	CcSEcCtD
Degarelix—Pruritus—Clonazepam—epilepsy syndrome	0.00026	0.000388	CcSEcCtD
Degarelix—Vomiting—Vigabatrin—epilepsy syndrome	0.00026	0.000388	CcSEcCtD
Degarelix—Skin disorder—Valproic Acid—epilepsy syndrome	0.00026	0.000388	CcSEcCtD
Degarelix—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000259	0.000387	CcSEcCtD
Degarelix—Oedema peripheral—Topiramate—epilepsy syndrome	0.000258	0.000386	CcSEcCtD
Degarelix—Hyperhidrosis—Valproic Acid—epilepsy syndrome	0.000258	0.000386	CcSEcCtD
Degarelix—Pruritus—Phenytoin—epilepsy syndrome	0.000258	0.000385	CcSEcCtD
Degarelix—Nausea—Levetiracetam—epilepsy syndrome	0.000258	0.000385	CcSEcCtD
Degarelix—Rash—Vigabatrin—epilepsy syndrome	0.000257	0.000384	CcSEcCtD
Degarelix—Dizziness—Felbamate—epilepsy syndrome	0.000257	0.000384	CcSEcCtD
Degarelix—Dermatitis—Vigabatrin—epilepsy syndrome	0.000257	0.000384	CcSEcCtD
Degarelix—Urethral disorder—Topiramate—epilepsy syndrome	0.000257	0.000384	CcSEcCtD
Degarelix—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000257	0.000383	CcSEcCtD
Degarelix—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000256	0.000383	CcSEcCtD
Degarelix—Vision blurred—Gabapentin—epilepsy syndrome	0.000256	0.000382	CcSEcCtD
Degarelix—Headache—Vigabatrin—epilepsy syndrome	0.000256	0.000382	CcSEcCtD
Degarelix—Hypertension—Pregabalin—epilepsy syndrome	0.000256	0.000382	CcSEcCtD
Degarelix—Vomiting—Diazepam—epilepsy syndrome	0.000256	0.000382	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—HBEGF—epilepsy syndrome	0.000255	0.000984	CbGpPWpGaD
Degarelix—Rash—Diazepam—epilepsy syndrome	0.000253	0.000378	CcSEcCtD
Degarelix—Dermatitis—Diazepam—epilepsy syndrome	0.000253	0.000378	CcSEcCtD
Degarelix—Arthralgia—Pregabalin—epilepsy syndrome	0.000252	0.000376	CcSEcCtD
Degarelix—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.000252	0.000376	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CDC42—epilepsy syndrome	0.000252	0.00097	CbGpPWpGaD
Degarelix—Dizziness—Zonisamide—epilepsy syndrome	0.000252	0.000376	CcSEcCtD
Degarelix—Headache—Diazepam—epilepsy syndrome	0.000252	0.000376	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GFAP—epilepsy syndrome	0.000252	0.00097	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GAL—epilepsy syndrome	0.000252	0.00097	CbGpPWpGaD
Degarelix—Diarrhoea—Clonazepam—epilepsy syndrome	0.000251	0.000375	CcSEcCtD
Degarelix—Anaemia—Gabapentin—epilepsy syndrome	0.000251	0.000375	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—AKT3—epilepsy syndrome	0.000251	0.000966	CbGpPWpGaD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.00025	0.000374	CcSEcCtD
Degarelix—Hypotension—Valproic Acid—epilepsy syndrome	0.00025	0.000373	CcSEcCtD
Degarelix—Asthenia—Carbamazepine—epilepsy syndrome	0.00025	0.000373	CcSEcCtD
Degarelix—Diarrhoea—Phenytoin—epilepsy syndrome	0.000249	0.000372	CcSEcCtD
Degarelix—Discomfort—Pregabalin—epilepsy syndrome	0.000249	0.000372	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CHRM3—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CASP2—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—GRM5—epilepsy syndrome	0.000249	0.000959	CbGpPWpGaD
Degarelix—Nausea—Fosphenytoin—epilepsy syndrome	0.000249	0.000371	CcSEcCtD
Degarelix—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000248	0.00037	CcSEcCtD
Degarelix—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000248	0.00037	CcSEcCtD
Degarelix—Vomiting—Felbamate—epilepsy syndrome	0.000247	0.000369	CcSEcCtD
Degarelix—Dry mouth—Pregabalin—epilepsy syndrome	0.000247	0.000368	CcSEcCtD
Degarelix—Pruritus—Carbamazepine—epilepsy syndrome	0.000246	0.000368	CcSEcCtD
Degarelix—Rash—Felbamate—epilepsy syndrome	0.000245	0.000366	CcSEcCtD
Degarelix—Eye disorder—Topiramate—epilepsy syndrome	0.000245	0.000366	CcSEcCtD
Degarelix—Dermatitis—Felbamate—epilepsy syndrome	0.000245	0.000366	CcSEcCtD
Degarelix—Malaise—Gabapentin—epilepsy syndrome	0.000245	0.000365	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—AVP—epilepsy syndrome	0.000244	0.000939	CbGpPWpGaD
Degarelix—Headache—Felbamate—epilepsy syndrome	0.000244	0.000364	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000243	0.000364	CcSEcCtD
Degarelix—Cardiac disorder—Topiramate—epilepsy syndrome	0.000243	0.000364	CcSEcCtD
Degarelix—Dizziness—Clonazepam—epilepsy syndrome	0.000243	0.000362	CcSEcCtD
Degarelix—Nausea—Vigabatrin—epilepsy syndrome	0.000243	0.000362	CcSEcCtD
Degarelix—Vomiting—Zonisamide—epilepsy syndrome	0.000242	0.000362	CcSEcCtD
Degarelix—Insomnia—Valproic Acid—epilepsy syndrome	0.000242	0.000361	CcSEcCtD
Degarelix—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000242	0.000361	CcSEcCtD
Degarelix—Asthenia—Lamotrigine—epilepsy syndrome	0.000241	0.00036	CcSEcCtD
Degarelix—Dizziness—Phenytoin—epilepsy syndrome	0.000241	0.00036	CcSEcCtD
Degarelix—Rash—Zonisamide—epilepsy syndrome	0.00024	0.000358	CcSEcCtD
Degarelix—Palpitations—Gabapentin—epilepsy syndrome	0.00024	0.000358	CcSEcCtD
Degarelix—Dermatitis—Zonisamide—epilepsy syndrome	0.00024	0.000358	CcSEcCtD
Degarelix—Dizziness—Oxcarbazepine—epilepsy syndrome	0.00024	0.000358	CcSEcCtD
Degarelix—Nausea—Diazepam—epilepsy syndrome	0.000239	0.000356	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CX3CR1—epilepsy syndrome	0.000239	0.00092	CbGpPWpGaD
Degarelix—Headache—Zonisamide—epilepsy syndrome	0.000239	0.000356	CcSEcCtD
Degarelix—Dyspnoea—Valproic Acid—epilepsy syndrome	0.000238	0.000356	CcSEcCtD
Degarelix—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000238	0.000355	CcSEcCtD
Degarelix—Angiopathy—Topiramate—epilepsy syndrome	0.000238	0.000355	CcSEcCtD
Degarelix—Pruritus—Lamotrigine—epilepsy syndrome	0.000238	0.000355	CcSEcCtD
Degarelix—Immune system disorder—Topiramate—epilepsy syndrome	0.000237	0.000354	CcSEcCtD
Degarelix—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000237	0.000354	CcSEcCtD
Degarelix—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000236	0.000353	CcSEcCtD
Degarelix—Chills—Topiramate—epilepsy syndrome	0.000235	0.000351	CcSEcCtD
Degarelix—Skin disorder—Pregabalin—epilepsy syndrome	0.000235	0.00035	CcSEcCtD
Degarelix—Hypertension—Gabapentin—epilepsy syndrome	0.000234	0.00035	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CX3CL1—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—BDKRB1—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CHRM2—epilepsy syndrome	0.000234	0.000902	CbGpPWpGaD
Degarelix—Hyperhidrosis—Pregabalin—epilepsy syndrome	0.000234	0.000349	CcSEcCtD
Degarelix—Vomiting—Clonazepam—epilepsy syndrome	0.000233	0.000348	CcSEcCtD
Degarelix—Decreased appetite—Valproic Acid—epilepsy syndrome	0.000232	0.000347	CcSEcCtD
Degarelix—Alopecia—Topiramate—epilepsy syndrome	0.000232	0.000346	CcSEcCtD
Degarelix—Vomiting—Phenytoin—epilepsy syndrome	0.000232	0.000346	CcSEcCtD
Degarelix—Rash—Clonazepam—epilepsy syndrome	0.000231	0.000346	CcSEcCtD
Degarelix—Dermatitis—Clonazepam—epilepsy syndrome	0.000231	0.000345	CcSEcCtD
Degarelix—Arthralgia—Gabapentin—epilepsy syndrome	0.000231	0.000345	CcSEcCtD
Degarelix—Nausea—Felbamate—epilepsy syndrome	0.000231	0.000345	CcSEcCtD
Degarelix—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000231	0.000344	CcSEcCtD
Degarelix—Vomiting—Oxcarbazepine—epilepsy syndrome	0.000231	0.000344	CcSEcCtD
Degarelix—Fatigue—Valproic Acid—epilepsy syndrome	0.00023	0.000344	CcSEcCtD
Degarelix—Dizziness—Carbamazepine—epilepsy syndrome	0.00023	0.000344	CcSEcCtD
Degarelix—Diarrhoea—Lamotrigine—epilepsy syndrome	0.00023	0.000344	CcSEcCtD
Degarelix—Headache—Clonazepam—epilepsy syndrome	0.00023	0.000343	CcSEcCtD
Degarelix—Rash—Phenytoin—epilepsy syndrome	0.00023	0.000343	CcSEcCtD
Degarelix—Mental disorder—Topiramate—epilepsy syndrome	0.00023	0.000343	CcSEcCtD
Degarelix—Dermatitis—Phenytoin—epilepsy syndrome	0.00023	0.000343	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.00023	0.000343	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CDC42—epilepsy syndrome	0.000229	0.000881	CbGpPWpGaD
Degarelix—Rash—Oxcarbazepine—epilepsy syndrome	0.000229	0.000341	CcSEcCtD
Degarelix—Constipation—Valproic Acid—epilepsy syndrome	0.000229	0.000341	CcSEcCtD
Degarelix—Pain—Valproic Acid—epilepsy syndrome	0.000229	0.000341	CcSEcCtD
Degarelix—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Degarelix—Headache—Phenytoin—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Degarelix—Erythema—Topiramate—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Degarelix—Malnutrition—Topiramate—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Degarelix—Discomfort—Gabapentin—epilepsy syndrome	0.000228	0.000341	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—GABBR1—epilepsy syndrome	0.000228	0.000877	CbGpPWpGaD
Degarelix—Headache—Oxcarbazepine—epilepsy syndrome	0.000227	0.000339	CcSEcCtD
Degarelix—Nausea—Zonisamide—epilepsy syndrome	0.000226	0.000338	CcSEcCtD
Degarelix—Dry mouth—Gabapentin—epilepsy syndrome	0.000226	0.000337	CcSEcCtD
Degarelix—Hypotension—Pregabalin—epilepsy syndrome	0.000226	0.000337	CcSEcCtD
Degarelix—Dizziness—Lamotrigine—epilepsy syndrome	0.000222	0.000332	CcSEcCtD
Degarelix—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000222	0.000331	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—AVP—epilepsy syndrome	0.000221	0.000853	CbGpPWpGaD
Degarelix—Vomiting—Carbamazepine—epilepsy syndrome	0.000221	0.00033	CcSEcCtD
Degarelix—Back pain—Topiramate—epilepsy syndrome	0.000221	0.00033	CcSEcCtD
Degarelix—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.00022	0.000329	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00022	0.000329	CcSEcCtD
Degarelix—Muscle spasms—Topiramate—epilepsy syndrome	0.00022	0.000328	CcSEcCtD
Degarelix—Rash—Carbamazepine—epilepsy syndrome	0.000219	0.000328	CcSEcCtD
Degarelix—Dermatitis—Carbamazepine—epilepsy syndrome	0.000219	0.000327	CcSEcCtD
Degarelix—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	0.000219	0.000326	CcSEcCtD
Degarelix—Insomnia—Pregabalin—epilepsy syndrome	0.000219	0.000326	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HRH3—epilepsy syndrome	0.000218	0.000841	CbGpPWpGaD
Degarelix—Nausea—Clonazepam—epilepsy syndrome	0.000218	0.000325	CcSEcCtD
Degarelix—Headache—Carbamazepine—epilepsy syndrome	0.000218	0.000325	CcSEcCtD
Degarelix—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000217	0.000324	CcSEcCtD
Degarelix—Nausea—Phenytoin—epilepsy syndrome	0.000217	0.000323	CcSEcCtD
Degarelix—Dyspnoea—Pregabalin—epilepsy syndrome	0.000215	0.000322	CcSEcCtD
Degarelix—Nausea—Oxcarbazepine—epilepsy syndrome	0.000215	0.000322	CcSEcCtD
Degarelix—Vision blurred—Topiramate—epilepsy syndrome	0.000215	0.000321	CcSEcCtD
Degarelix—Skin disorder—Gabapentin—epilepsy syndrome	0.000215	0.000321	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—OPRM1—epilepsy syndrome	0.000215	0.000828	CbGpPWpGaD
Degarelix—Hyperhidrosis—Gabapentin—epilepsy syndrome	0.000214	0.00032	CcSEcCtD
Degarelix—Vomiting—Lamotrigine—epilepsy syndrome	0.000214	0.000319	CcSEcCtD
Degarelix—Urticaria—Valproic Acid—epilepsy syndrome	0.000212	0.000317	CcSEcCtD
Degarelix—Rash—Lamotrigine—epilepsy syndrome	0.000212	0.000317	CcSEcCtD
Degarelix—Ill-defined disorder—Topiramate—epilepsy syndrome	0.000212	0.000316	CcSEcCtD
Degarelix—Dermatitis—Lamotrigine—epilepsy syndrome	0.000212	0.000316	CcSEcCtD
Degarelix—Abdominal pain—Valproic Acid—epilepsy syndrome	0.000211	0.000315	CcSEcCtD
Degarelix—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000211	0.000315	CcSEcCtD
Degarelix—Anaemia—Topiramate—epilepsy syndrome	0.000211	0.000315	CcSEcCtD
Degarelix—Headache—Lamotrigine—epilepsy syndrome	0.000211	0.000315	CcSEcCtD
Degarelix—Decreased appetite—Pregabalin—epilepsy syndrome	0.00021	0.000314	CcSEcCtD
Degarelix—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000209	0.000311	CcSEcCtD
Degarelix—Fatigue—Pregabalin—epilepsy syndrome	0.000208	0.000311	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—CCR5—epilepsy syndrome	0.000207	0.000799	CbGpPWpGaD
Degarelix—Hypotension—Gabapentin—epilepsy syndrome	0.000207	0.000309	CcSEcCtD
Degarelix—Nausea—Carbamazepine—epilepsy syndrome	0.000207	0.000309	CcSEcCtD
Degarelix—Pain—Pregabalin—epilepsy syndrome	0.000207	0.000308	CcSEcCtD
Degarelix—Constipation—Pregabalin—epilepsy syndrome	0.000207	0.000308	CcSEcCtD
Degarelix—Malaise—Topiramate—epilepsy syndrome	0.000206	0.000307	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCR3—epilepsy syndrome	0.000203	0.000782	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—HTR2A—epilepsy syndrome	0.000203	0.000782	CbGpPWpGaD
Degarelix—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000202	0.000301	CcSEcCtD
Degarelix—Palpitations—Topiramate—epilepsy syndrome	0.000202	0.000301	CcSEcCtD
Degarelix—Insomnia—Gabapentin—epilepsy syndrome	0.0002	0.000299	CcSEcCtD
Degarelix—Nausea—Lamotrigine—epilepsy syndrome	0.0002	0.000298	CcSEcCtD
Degarelix—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000199	0.000297	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—NPY—epilepsy syndrome	0.000198	0.000762	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—ATP2A2—epilepsy syndrome	0.000198	0.000762	CbGpPWpGaD
Degarelix—Gastrointestinal pain—Pregabalin—epilepsy syndrome	0.000198	0.000295	CcSEcCtD
Degarelix—Dyspnoea—Gabapentin—epilepsy syndrome	0.000198	0.000295	CcSEcCtD
Degarelix—Hypertension—Topiramate—epilepsy syndrome	0.000197	0.000294	CcSEcCtD
Degarelix—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000197	0.000294	CcSEcCtD
Degarelix—Arthralgia—Topiramate—epilepsy syndrome	0.000194	0.00029	CcSEcCtD
Degarelix—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	0.000193	0.000288	CcSEcCtD
Degarelix—Decreased appetite—Gabapentin—epilepsy syndrome	0.000193	0.000288	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—AGT—epilepsy syndrome	0.000193	0.000742	CbGpPWpGaD
Degarelix—Discomfort—Topiramate—epilepsy syndrome	0.000192	0.000287	CcSEcCtD
Degarelix—Urticaria—Pregabalin—epilepsy syndrome	0.000192	0.000287	CcSEcCtD
Degarelix—Asthenia—Valproic Acid—epilepsy syndrome	0.000192	0.000286	CcSEcCtD
Degarelix—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	0.000191	0.000286	CcSEcCtD
Degarelix—Fatigue—Gabapentin—epilepsy syndrome	0.000191	0.000285	CcSEcCtD
Degarelix—Body temperature increased—Pregabalin—epilepsy syndrome	0.000191	0.000285	CcSEcCtD
Degarelix—Abdominal pain—Pregabalin—epilepsy syndrome	0.000191	0.000285	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HSPB1—epilepsy syndrome	0.000191	0.000735	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL3—epilepsy syndrome	0.000191	0.000735	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CRH—epilepsy syndrome	0.000191	0.000735	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—OXT—epilepsy syndrome	0.000191	0.000735	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CXCL2—epilepsy syndrome	0.000191	0.000735	CbGpPWpGaD
Degarelix—Dry mouth—Topiramate—epilepsy syndrome	0.00019	0.000284	CcSEcCtD
Degarelix—Pain—Gabapentin—epilepsy syndrome	0.000189	0.000283	CcSEcCtD
Degarelix—Constipation—Gabapentin—epilepsy syndrome	0.000189	0.000283	CcSEcCtD
Degarelix—Pruritus—Valproic Acid—epilepsy syndrome	0.000189	0.000282	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—CCR5—epilepsy syndrome	0.000188	0.000725	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—HTR2A—epilepsy syndrome	0.000184	0.00071	CbGpPWpGaD
Degarelix—Diarrhoea—Valproic Acid—epilepsy syndrome	0.000183	0.000273	CcSEcCtD
Degarelix—Nervous system disorder—Topiramate—epilepsy syndrome	0.000183	0.000273	CcSEcCtD
Degarelix—Feeling abnormal—Gabapentin—epilepsy syndrome	0.000183	0.000273	CcSEcCtD
Degarelix—Gastrointestinal pain—Gabapentin—epilepsy syndrome	0.000181	0.00027	CcSEcCtD
Degarelix—Skin disorder—Topiramate—epilepsy syndrome	0.000181	0.00027	CcSEcCtD
Degarelix—Hyperhidrosis—Topiramate—epilepsy syndrome	0.00018	0.000269	CcSEcCtD
Degarelix—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000178	0.000266	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—PRKCB—epilepsy syndrome	0.000178	0.000685	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TSC1—epilepsy syndrome	0.000177	0.000684	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PTK2B—epilepsy syndrome	0.000177	0.000684	CbGpPWpGaD
Degarelix—Dizziness—Valproic Acid—epilepsy syndrome	0.000177	0.000264	CcSEcCtD
Degarelix—Urticaria—Gabapentin—epilepsy syndrome	0.000176	0.000263	CcSEcCtD
Degarelix—Body temperature increased—Gabapentin—epilepsy syndrome	0.000175	0.000261	CcSEcCtD
Degarelix—Abdominal pain—Gabapentin—epilepsy syndrome	0.000175	0.000261	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—AGT—epilepsy syndrome	0.000175	0.000674	CbGpPWpGaD
Degarelix—Hypotension—Topiramate—epilepsy syndrome	0.000174	0.00026	CcSEcCtD
Degarelix—Asthenia—Pregabalin—epilepsy syndrome	0.000173	0.000259	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CCR2—epilepsy syndrome	0.000173	0.000665	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NTRK2—epilepsy syndrome	0.000173	0.000665	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SST—epilepsy syndrome	0.000173	0.000665	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—DUSP6—epilepsy syndrome	0.000171	0.000659	CbGpPWpGaD
Degarelix—Pruritus—Pregabalin—epilepsy syndrome	0.000171	0.000255	CcSEcCtD
Degarelix—Vomiting—Valproic Acid—epilepsy syndrome	0.00017	0.000254	CcSEcCtD
Degarelix—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.00017	0.000254	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ADRA2A—epilepsy syndrome	0.000169	0.000651	CbGpPWpGaD
Degarelix—Insomnia—Topiramate—epilepsy syndrome	0.000169	0.000252	CcSEcCtD
Degarelix—Rash—Valproic Acid—epilepsy syndrome	0.000169	0.000252	CcSEcCtD
Degarelix—Dermatitis—Valproic Acid—epilepsy syndrome	0.000168	0.000251	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PLAT—epilepsy syndrome	0.000168	0.000648	CbGpPWpGaD
Degarelix—Headache—Valproic Acid—epilepsy syndrome	0.000167	0.00025	CcSEcCtD
Degarelix—Dyspnoea—Topiramate—epilepsy syndrome	0.000166	0.000248	CcSEcCtD
Degarelix—Diarrhoea—Pregabalin—epilepsy syndrome	0.000165	0.000247	CcSEcCtD
Degarelix—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000163	0.000244	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—CXCL12—epilepsy syndrome	0.000162	0.000625	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—BDKRB2—epilepsy syndrome	0.000162	0.000625	CbGpPWpGaD
Degarelix—Decreased appetite—Topiramate—epilepsy syndrome	0.000162	0.000242	CcSEcCtD
Degarelix—GNRHR—GPCR downstream signaling—POMC—epilepsy syndrome	0.000162	0.000624	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—PRKCB—epilepsy syndrome	0.000162	0.000622	CbGpPWpGaD
Degarelix—Gastrointestinal disorder—Topiramate—epilepsy syndrome	0.000161	0.00024	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—IL6ST—epilepsy syndrome	0.000161	0.00062	CbGpPWpGaD
Degarelix—Fatigue—Topiramate—epilepsy syndrome	0.000161	0.00024	CcSEcCtD
Degarelix—Dizziness—Pregabalin—epilepsy syndrome	0.00016	0.000239	CcSEcCtD
Degarelix—Pain—Topiramate—epilepsy syndrome	0.000159	0.000238	CcSEcCtD
Degarelix—Constipation—Topiramate—epilepsy syndrome	0.000159	0.000238	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—JUNB—epilepsy syndrome	0.000159	0.000614	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CNR1—epilepsy syndrome	0.000159	0.000614	CbGpPWpGaD
Degarelix—Asthenia—Gabapentin—epilepsy syndrome	0.000159	0.000237	CcSEcCtD
Degarelix—Nausea—Valproic Acid—epilepsy syndrome	0.000159	0.000237	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—PLCB1—epilepsy syndrome	0.000159	0.000612	CbGpPWpGaD
Degarelix—Pruritus—Gabapentin—epilepsy syndrome	0.000157	0.000234	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR7—epilepsy syndrome	0.000155	0.000599	CbGpPWpGaD
Degarelix—Vomiting—Pregabalin—epilepsy syndrome	0.000154	0.000229	CcSEcCtD
Degarelix—Feeling abnormal—Topiramate—epilepsy syndrome	0.000154	0.000229	CcSEcCtD
Degarelix—Gastrointestinal pain—Topiramate—epilepsy syndrome	0.000152	0.000228	CcSEcCtD
Degarelix—Rash—Pregabalin—epilepsy syndrome	0.000152	0.000227	CcSEcCtD
Degarelix—Dermatitis—Pregabalin—epilepsy syndrome	0.000152	0.000227	CcSEcCtD
Degarelix—Diarrhoea—Gabapentin—epilepsy syndrome	0.000152	0.000226	CcSEcCtD
Degarelix—Headache—Pregabalin—epilepsy syndrome	0.000151	0.000226	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HBEGF—epilepsy syndrome	0.000151	0.000581	CbGpPWpGaD
Degarelix—Urticaria—Topiramate—epilepsy syndrome	0.000148	0.000221	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—AKT3—epilepsy syndrome	0.000148	0.000571	CbGpPWpGaD
Degarelix—Body temperature increased—Topiramate—epilepsy syndrome	0.000147	0.00022	CcSEcCtD
Degarelix—Abdominal pain—Topiramate—epilepsy syndrome	0.000147	0.00022	CcSEcCtD
Degarelix—GNRHR—Signaling by GPCR—POMC—epilepsy syndrome	0.000147	0.000567	CbGpPWpGaD
Degarelix—Dizziness—Gabapentin—epilepsy syndrome	0.000147	0.000219	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—ADAM10—epilepsy syndrome	0.000145	0.000557	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—CCL2—epilepsy syndrome	0.000144	0.000555	CbGpPWpGaD
Degarelix—Nausea—Pregabalin—epilepsy syndrome	0.000144	0.000214	CcSEcCtD
Degarelix—Vomiting—Gabapentin—epilepsy syndrome	0.000141	0.00021	CcSEcCtD
Degarelix—Rash—Gabapentin—epilepsy syndrome	0.00014	0.000209	CcSEcCtD
Degarelix—Dermatitis—Gabapentin—epilepsy syndrome	0.00014	0.000208	CcSEcCtD
Degarelix—Headache—Gabapentin—epilepsy syndrome	0.000139	0.000207	CcSEcCtD
Degarelix—Hypersensitivity—Topiramate—epilepsy syndrome	0.000137	0.000205	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—S100B—epilepsy syndrome	0.000137	0.000527	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SOCS3—epilepsy syndrome	0.000135	0.000522	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CDC42—epilepsy syndrome	0.000135	0.000521	CbGpPWpGaD
Degarelix—Asthenia—Topiramate—epilepsy syndrome	0.000134	0.0002	CcSEcCtD
Degarelix—Pruritus—Topiramate—epilepsy syndrome	0.000132	0.000197	CcSEcCtD
Degarelix—Nausea—Gabapentin—epilepsy syndrome	0.000132	0.000196	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—AVP—epilepsy syndrome	0.000131	0.000504	CbGpPWpGaD
Degarelix—Diarrhoea—Topiramate—epilepsy syndrome	0.000128	0.00019	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HES1—epilepsy syndrome	0.000124	0.000477	CbGpPWpGaD
Degarelix—Dizziness—Topiramate—epilepsy syndrome	0.000123	0.000184	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—FYN—epilepsy syndrome	0.00012	0.000463	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—H2AFX—epilepsy syndrome	0.00012	0.000462	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MEF2C—epilepsy syndrome	0.00012	0.000461	CbGpPWpGaD
Degarelix—Vomiting—Topiramate—epilepsy syndrome	0.000119	0.000177	CcSEcCtD
Degarelix—Rash—Topiramate—epilepsy syndrome	0.000118	0.000175	CcSEcCtD
Degarelix—Dermatitis—Topiramate—epilepsy syndrome	0.000117	0.000175	CcSEcCtD
Degarelix—Headache—Topiramate—epilepsy syndrome	0.000117	0.000174	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—YWHAZ—epilepsy syndrome	0.000116	0.000446	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—NGF—epilepsy syndrome	0.000114	0.000441	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCR5—epilepsy syndrome	0.000111	0.000429	CbGpPWpGaD
Degarelix—Nausea—Topiramate—epilepsy syndrome	0.000111	0.000165	CcSEcCtD
Degarelix—GNRHR—Signaling Pathways—HTR2A—epilepsy syndrome	0.000109	0.000419	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—TSC2—epilepsy syndrome	0.000103	0.000398	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AGT—epilepsy syndrome	0.000103	0.000398	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—APOE—epilepsy syndrome	0.000101	0.00039	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—KDR—epilepsy syndrome	9.91e-05	0.000382	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—PRKCB—epilepsy syndrome	9.54e-05	0.000368	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—IL6ST—epilepsy syndrome	9.5e-05	0.000366	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—POMC—epilepsy syndrome	8.69e-05	0.000335	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CCL2—epilepsy syndrome	8.5e-05	0.000328	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—FGF2—epilepsy syndrome	7.69e-05	0.000296	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—RELA—epilepsy syndrome	7.14e-05	0.000275	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MTOR—epilepsy syndrome	7e-05	0.00027	CbGpPWpGaD
Degarelix—GNRHR—GPCR downstream signaling—AKT1—epilepsy syndrome	6.5e-05	0.00025	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—CASP3—epilepsy syndrome	6.44e-05	0.000248	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—JUN—epilepsy syndrome	6.25e-05	0.000241	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—MMP9—epilepsy syndrome	6.08e-05	0.000234	CbGpPWpGaD
Degarelix—GNRHR—Signaling by GPCR—AKT1—epilepsy syndrome	5.9e-05	0.000227	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—SRC—epilepsy syndrome	5.61e-05	0.000216	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—VEGFA—epilepsy syndrome	5.46e-05	0.00021	CbGpPWpGaD
Degarelix—GNRHR—Signaling Pathways—AKT1—epilepsy syndrome	3.48e-05	0.000134	CbGpPWpGaD
